1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Hualan Biological Engineering Inc.
  6. News
  7. Summary
    002007   CNE000001JN8

HUALAN BIOLOGICAL ENGINEERING INC.

(002007)
  Report
End-of-day quote Shenzhen Stock Exchange  -  05-15
16.67 CNY   -1.59%
04/29Hualan Biological Engineering Inc. Approves Cash Dividend for the Year 2021
CI
04/28Hualan Biological Engineering Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
03/30Hualan Biological Engineering Inc. Proposes Final Cash Dividend for the Year 2021
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Hualan Biological Engineering Inc. Reports Earnings Results for the Nine Months Ended September 30, 2021

10/29/2021 | 03:55am EDT

Hualan Biological Engineering Inc. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 3,361.07 million compared to CNY 3,072.8 million a year ago. Revenue was CNY 3,361.07 million compared to CNY 3,072.8 million a year ago. Net income was CNY 1,056.76 million compared to CNY 964.19 million a year ago. Basic earnings per share from continuing operations was CNY 0.5803 compared to CNY 0.5302 a year ago. Diluted earnings per share from continuing operations was CNY 0.5803 compared to CNY 0.5296 a year ago.


ę S&P Capital IQ 2021
All news about HUALAN BIOLOGICAL ENGINEERING INC.
04/29Hualan Biological Engineering Inc. Approves Cash Dividend for the Year 2021
CI
04/28Hualan Biological Engineering Inc. Reports Earnings Results for the First Quarter Ended..
CI
03/30Hualan Biological Engineering Inc. Proposes Final Cash Dividend for the Year 2021
CI
03/29Hualan Biological Engineering Inc. Reports Earnings Results for the Full Year Ended Dec..
CI
2021Hualan Biological Engineering Inc. Reports Earnings Results for the Nine Months Ended S..
CI
2021Hualan Biological Engineering Inc. Reports Earnings Results for the Half Year Ended Jun..
CI
2021Hualan Biological Engineering Inc. Announces Final Cash Dividend on A Shares for the Ye..
CI
2021Hualan Biological Engineering Inc. Reports Earnings Results for the First Quarter Ended..
CI
2021HUALAN BIOLOGICAL ENGINEERING : to Produce Russia's Sputnik COVID-19 Vaccine in China
MT
2021Hualan Biological Engineering Inc. Proposes Final Dividend for 2020
CI
More news
Financials
Sales 2022 4 896 M 722 M 722 M
Net income 2022 1 472 M 217 M 217 M
Net cash 2022 2 051 M 302 M 302 M
P/E ratio 2022 20,7x
Yield 2022 1,23%
Capitalization 30 412 M 4 483 M 4 483 M
EV / Sales 2022 5,79x
EV / Sales 2023 4,26x
Nbr of Employees 2 927
Free-Float 52,7%
Chart HUALAN BIOLOGICAL ENGINEERING INC.
Duration : Period :
Hualan Biological Engineering Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HUALAN BIOLOGICAL ENGINEERING INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 16,67 CNY
Average target price 32,08 CNY
Spread / Average Target 92,4%
EPS Revisions
Managers and Directors
Bei Fan General Manager & Director
Jun Min Xie Chief Financial Officer & Board Secretary
Kang An Chairman
Chao Yuan Ma Chairman-Supervisory Board
Yun Long Wang Independent Director
Sector and Competitors